G Mining Ventures Provides Tocantinzinho Project Update

G Mining Ventures Provides Tocantinzinho Project Update All amounts are in USD unless stated otherwise TSX: GMINOTCQX: GMINF Project remains on schedule and on budget for commercial production in H2-2024 Total project progress of 87% with construction 89% complete Total spending to date of $433 million (95% of project total) Updated virtual site tour available … Read more

Ahead of March 25 Deadline, LKLSG Alerts Evolution AB (publ) (EVVTY) Shareholders of an Imminent Securities Class Action Lawsuit

MIAMI, March 23, 2024 /PRNewswire/ — Levine Kellogg Lehman Schneider + Grossman LLP (LKLSG) is informing investors in the Swedish gaming firm Evolution AB (publ) (“the Company” or “Evolution AB”) (OTC: EVVTY) about a newly initiated securities class action lawsuit and the nearing deadline for investors wishing to be designated as the lead plaintiff in … Read more

LUMIX S 28-200mm F4-7.1 MACRO O.I.S. (S-R28200)

A wide and long zoom range of 28-200mm, that fits all in the palm of your hand NEWARK, N.J., Feb. 21, 2024 /PRNewswire/ — Panasonic is pleased to introduce the LUMIX S 28-200mm F4-7.1 MACRO O.I.S. (S-R28200) lens based on the L-Mount system standard. Designed with meticulous attention to detail in optics and mechanics, the … Read more

Imlifidase met primary endpoint in 16-HMedIdes-12 phase 2 trial in patients with AMR following kidney transplantation

Statistically significant reduction in donor-specific antibodies (DSAs) observed among imlifidase patients within five days of treatment as compared to standard of care LUND, Sweden, Dec. 14, 2023 /PRNewswire/ — Hansa Biopharma, “Hansa” (Nasdaq Stockholm: HNSA), today announced full results from the 16-HMedIdeS-12 phase 2 trial in patients with antibody mediated rejection (AMR) episodes following a … Read more